Market Research Logo

Pharmaceuticals Market Research Reports & Industry Analysis

The pharmaceutical industry is directly impacted by the research conducted with prescription drugs, vaccines, and OTC drugs being manufactured based on findings from the study of life sciences. Clinical trials are conducted to ensure that products being developed are tested on how well they work on individuals affected by the diseases or conditions they are created to treat. The market research available can provide investors and analysts credible information on the direction of pharmaceuticals, anesthesia, drug delivery, pricing, regulations and policy being developed to ensure that knowledgeable and informed decisions are made regarding industry direction.
...Show More ...Show Less


Pharmaceuticals Industry Research & Market Reports

  • Global Pharma Handbook 2019

    Global Pharma Handbook 2019 A data-rich report that gives you insight into the structures,trends, and regulations driving the World's largest pharmaceutical markets Read More

  • European Pharma Handbook 2019

    European Pharma Handbook 2019 A data-rich report that gives you insight into the structures,trends, and regulations driving the European pharmaceutical market Read More

  • 2019 Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers

    ... circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current ... Read More

  • 2019 Global Cancer Diagnostics Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants

    ... presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. ... Read More

  • Sri Lanka Pharmaceuticals & Healthcare Q2 2019

    ... streamline regulatoryprocesses. While the local pharmaceutical market will continue to grow on the back of economic development and the risingburden of chronic diseases, government measures targeting drug prices will continue to pose risks to drugmakers. Read More

  • Ukraine Pharmaceuticals & Healthcare Q2 2019

    ... healthcare services, and the imminentimplementation of the National Health System should boost access to services. However, we note that poor administration willcontinue to hinder positive outcomes and the short-term impact of reform may be muted. Read More

  • United Kingdom Pharmaceuticals & Healthcare Q2 2019

    ... is largely avoided. In this scenario, theregulatory landscape looks largely unchanged and, therefore, the market outlook is in line with current trends at low single-digitgrowth. A hard Brexit outcome where the UK leaves the EU ... Read More

  • Zambia Pharmaceuticals & Healthcare Q2 2019

    ... and counterfeit drugs. Imported medicines (mostly generic drugs)continue to meet the bulk of demand although the Zambian government is making concerted efforts to improve conditions forlocal drug manufactures and thus reduce the country's import reliance. Read More

  • Croatia Pharmaceuticals & Healthcare Q2 2019

    ... driven an ageingpopulation and high disease burden. Although this demographic profile is favourable to innovative drugmakers, patented drug saleswill be limited by the government’s drug pricing and reimbursement policies as well as other cost-containment measures. Read More

  • Honduras Pharmaceuticals & Healthcare Q2 2019

    ... the market will remainreliant on low-value generic imports. We expect weak growth for medicine sales in the coming years, as institutional corruption andan inadequate regulatory enforcement will continue to make Honduras one of the least ... Read More

  • Hong Kong Pharmaceuticals & Healthcare Q2 2019

    ... As part of this process, the Department of Health's strategic framework for the prevention andcontrol of NCDs seeks long-term improvement in the population's health through promoting healthier diets, physical activity and areduction in alcohol-related harm. Read More

  • Venezuela Pharmaceuticals & Healthcare Q2 2019

    ... communicablediseases illustrate a healthcare system in crisis, as hospitals and pharmacies struggle to maintain sufficient medicine supplies. WithPresident Nicolás Maduro likely to keep a firm grip on power, we believe access to medicines and public ... Read More

  • Iraq Pharmaceuticals & Healthcare Q2 2019

    ... Competitionamong suppliers, including in the health sector, will intensify as the country resumes economic activity over the coming years. Lowpurchasing power, persistent political risks and structural challenges will limit multinational investor opportunity in the near ... Read More

  • Vietnam Pharmaceuticals & Healthcare Q2 2019

    ... will challenge foreign investment into the sector.Highlighting the market's longer-term potential, some multinational drugmakers have shown their willingness to do business in thecountry, though the majority choose to operate indirectly to minimise the risks involved. Read More

  • Panama Pharmaceuticals & Healthcare Q2 2019

    ... if successfully implemented, towards improving access to healthcare. While the small domestic drug market will limitdrugmaker opportunity, Panama will continue to attract some level of pharmaceutical investment due to its strategic position as alogistics and ... Read More

  • Bahrain Pharmaceuticals & Healthcare Q2 2019

    ... a rise in chronic illness such as diabetes andcancer, a result of its ageing population and rising obesity levels. Government ambitions to thwart growth of the non-communicabledisease burden will provide opportunities to prescription drugmakers over ... Read More

  • Finland Pharmaceuticals & Healthcare Q2 2019

    ... healthcare reformsand creating an uncertain market for drugmakers and healthcare providers. Nonetheless, as with many of its Western Europeanpeers, an ageing population and high per capita spending will ensure the demand for innovative medicines remain ... Read More

  • OBGYNs

    ... Demand is driven by population growth and private insurance and government health care policies. In private practices, profitability depends on insurance participation and reimbursements, patient volume, and administrative efficiency. In hospitals and outpatient clinics, profitability ... Read More

  • 2019 Ceva: Business Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

    ... and profitability. This new report from VPG provides strategic assessment of Ceva's technological know-how, marketing tactics and strategic directions in the global animal health market. Technological Know-How - Internally developed and acquired animal health technologies, ... Read More

  • 2019 Merck Animal Health: Business Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

    ... survival, growth and profitability. This new report from VPG provides strategic assessment of Merck's technological know-how, marketing tactics and strategic directions in the global animal health market. Technological Know-How - Internally developed and acquired animal ... Read More

  • 2019 Phibro: Business Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

    ... and profitability. This new report from VPG provides strategic assessment of Phibro's technological know-how, marketing tactics and strategic directions in the global animal health market. Technological Know-How - Internally developed and acquired animal health technologies, ... Read More

  • 2019 Zoetis: Business Challenges, Technological Capabilities, Marketing Tactics, Strategic Direction

    ... and profitability. This new report from VPG provides strategic assessment of Zoetis' technological know-how, marketing tactics and strategic directions in the global animal health market. Technological Know-How - Internally developed and acquired animal health technologies, ... Read More

  • ARUP Laboratories - Strategic SWOT Analysis Review

    ... key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Business description ... Read More

  • F. Hoffmann-La Roche Ltd (ROG) - Financial and Strategic SWOT Analysis Review

    ... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ... Read More

  • Senju Pharmaceutical Co Ltd - Strategic SWOT Analysis Review

    ... key employees, key competitors and major products and services. This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope ... Read More

< prev 1 3 4 5 6 7 8 9 10